The Big Taboo

Seroba’s investment in Atlantic Therapeutics has helped fund additional clinical trials of INNOVO®, a pair of really smart shorts that delivers muscle stimulations to strengthen the pelvic floor.

The positive results of those trials are now being used to support the new advertising for INNOVO®, which aired on UK and French TV channels in 2018.

If you haven’t seen it yet, you can check out the INNOVO® TV ad on the right.

United States:

In June 2019, following FDA clearance, INNOVO® was launched in the States.  New York Live is a daily lifestyle show airing weekdays at 12:30 p.m. on NBC 4.  Check out this straight-talking interview with Dr Nina that aired on June 17th.

It’s all about the Science

With one in four women suffering from bladder weakness, you can be certain that someone you know personally is affected by this problem.

  • Interested in the understanding what exactly is meant by ‘Bladder Weakness’?
  • What the causes of incontinence are?
  • Or how INNOVO® is providing a solution to a problem that nobody talks about?

Then check out the ‘Science bit’ here.

Perfect Pelvic Contractions - effortlessly.

The Big Taboo 2

INNOVO® Shorts – The non-invasive, long-lasting solution to treat the root cause of bladder weakness.  INNOVO® delivers 180 perfect pelvic contractions in every 30-minute session safely and effortlessly in the comfort of your own home.

Watch this one-minute video about how to use INNOVO®

Atlantic Therapeutics

Seroba’s portfolio company, Atlantic Therapeutics with its HQ in Galway, Ireland is the innovative company that developed the INNOVO® Shorts technology.

There’s a dedicated website for anyone interested in learning more about INNOVO®With the catchy website name of, this site features customer testimonials, a dedicated blog, information for practitioners, customer reviews and more.  You can visit the INNOVO® website here.

For more about Seroba’s portfolio company, Atlantic Therapeutics, go to

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top